Abstract:The vpr gene of human immunodeficiency virus type 1 (HIV-1) plays an important role in the pathogenicity of viruses. Previous studies showed that mutation of certain sites in HIV-1 Vpr amino acid sequences might influence the clinical process of infected individuals and attenuate its apoptosis-inducing capacity on infected cells. The present study was designed to transfect hela cells with several HIV-1 vpr fragments carrying specific mutation sites, and to observe the distinction of apoptosis-inducing effects of different HIV-1 vpr variant fragments on host cells and explore the possible mechanisms. According to the previous results, 14 typical vpr variant fragments were chosen from Chinese HIV-1 infected individuals. After PCR amplification of vpr gene, the products were purified and double digested with Hind and BamHI. Then pcDNA3.1 (+) eukaryotic expression plasmids were used for the ligation and transduction experiments. The recombinant plasmids were transiently transfected into Hela cells with liposomes, and meanwhile the blank cell and empty vector cell were established as control. RT-PCR was used to detect the mRNA expression of target genes; fluorescent microscope for observing apoptotic cells with Hoechst staining; DNA agarose electrophoresis for detecting apoptotic gradient band; Annexin assay for detecting cell apoptosis; and Caspase activity test for exploring the pathway of cell apoptosis. After transfected with 14 vpr gene segments, the Hela cells exhibited various apoptosis-inducing capabilities. We found that the HIV-1 Vpr segments with mutation at the 70(th), 85(th), 86(th), or 94(th) site showed lower apoptosis-inducing capabilities than other segments on Hela cells, and the apoptosis-inducing ability of HIV-1 vpr gene on host cells might be related to its subtype. Meanwhile, we found that the Caspase3 activity of transfected cell carrying these mutated fragment sites was decreased as compared to the cell with other fragments. This study firstly found that the HIV-1 Vpr fragments with the 70(th), 85(th), 86(th), or 94(th) site mutation might attenuate their apoptosis-inducing abilities on Hela cells. One of the mechanisms might be the attenuation of Caspase-3 activity.

Suppressive Effect of Elongation Factor 2 on Apoptosis Induced by Hiv-1 Viral Protein R

The Hiv-1 Vif Protein Mediates Degradation Of Vpr And Reduces Vpr-Induced Cell Cycle Arrest

Multifactorial role of HIV-Vpr in cell apoptosis revealed by a naturally truncated 54aa variant

The Apoptosis-Inducing Effects of HIV Vpr Recombinant Eukaryotic Expression Vectors with Different Mutation Sites on Transfected Hela Cells.

Evolutionarily Conserved Pressure for the Existence of Distinct G2/M Cell Cycle Arrest and A3H Inactivation Functions in HIV-1 Vif.

Genetic Variance in the HIV-1 Founder Virus Vpr Affects Its Ability to Induce Cell Cycle G₂arrest and Cell Apoptosis.

Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.

The study of the expressions of apoptosis and its related protein by knockdown of human immunodeficiency virus-1 vpr gene

Structural Basis of Antagonism of Human APOBEC3F by HIV-1 Vif

Identification of an Hiv-1 Replication Inhibitor Which Rescues Host Restriction Factor Apobec3g in Vif-Apobec3g Complex

The Vif Accessory Protein Alters the Cell Cycle of Human Immunodeficiency Virus Type 1 Infected Cells (45.15)

[Effects of Different Mutated Sites in Vpr Gene of HIV on Apoptosis of Host Cells: Experiment with HeLa Cells].

Regulation of Apobec3f and Human Immunodeficiency Virus Type 1 Vif by Vif-Cul5-Elonb/C E3 Ubiquitin Ligase

Endogenous HIV-1 Vpr-mediated Apoptosis and Proteome Alteration of Human T-cell Leukemia Virus-1 Transformed C8166 Cells

The HIV-1 vpr R77Q Mutant Induces Apoptosis, G2 Cell Cycle Arrest, and Lower Production of Pro-Inflammatory Cytokines in Human CD4+ T Cells

Vif Hijacks CBF-β to Degrade APOBEC3G and Promote HIV-1 Infection

Vpr Targets TET2 for Degradation by CRL4VprBP E3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication

Structural and Functional Study of Apoptosis-linked Gene-2·Heme-binding Protein 2 Interactions in HIV-1 Production.

Human cytomegalovirus UL36 inhibits IRF3-dependent immune signaling to counterbalance its immunoenhancement as apoptotic inhibitor

Influence Of Primate Lentiviral Vif And Proteasome Inhibitors On Human Immunodeficiency Virus Type 1 Virion Packaging Of Apobec3g

A Function of Targeting Fusion Protein XE-TNFom2 to Lead Apoptosis in Cells Infected by HIV/SIV